Literature DB >> 452947

Follow-up studies of joint complications in yersiniosis.

J L Kalliomäki, R Leino.   

Abstract

In 1971-73, 60 patients were hospitalized for an infectios disease caused by Y. enterocolitica serotypes III and IX or Y. pseudotuberculosis serotype I. In the spring of 1977 a follow-up study was carried out with 52 of these patients, one patient having died from intestinal perforation evidently resulting from yersiniosis-induced amyloidosis and colitis. The follow-up study showed that two patients had symptoms of sacroilitis, one had developed an apparent rheumatoid arthritis after yersiniosis and one had joint plans and a high serum rheumatoid factor titer with no objective joint changes. All results from kidney and liver studies were normal. No brucellosis antibodies were found in the follow-up study. Twelve patients had antibody titers against Y. enterocolitica serotype III.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 452947     DOI: 10.1111/j.0954-6820.1979.tb06095.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  12 in total

1.  Expression, purification, and characterization of the humoral immune response to recombinant MyfA protein of Yersinia enterocolitica.

Authors:  W Rastawicki; R Gierczyński
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-20       Impact factor: 3.267

2.  Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Parviainen; J Uksila; R Vainionpää; A Toivanen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

3.  Sarcoidosis and Yersinia enterocolitica.

Authors:  L T Vlasveld
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

4.  Acute anterior uveitis after yersinia infection.

Authors:  L Mattila; K Granfors; A Toivanen
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

5.  Antibodies to arthritis-associated microbes in inflammatory joint diseases.

Authors:  O Mäki-Ikola; M K Viljanen; S Tiitinen; P Toivanen; K Granfors
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

6.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

7.  The Yersinia enterocolitica infection in acute abdominal surgery. A clinical study with a 5-year follow-up period.

Authors:  A Saebø
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

8.  Incidence of Yersinia enterocolitica antibodies in patients with inflammatory joint diseases.

Authors:  V Tamburrino; R Monno; M A Valenza; R Numo
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

9.  Persistence of Yersinia enterocolitica in man.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J Heesemann
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

10.  Follow-up study of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis.

Authors:  M Leirisalo-Repo; G Skylv; M Kousa
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.